FDA Approves Obesity Pill From Eli Lilly

Date:

US NewsThe pill can be taken without food or water, its manufacturer says.An Eli Lilly and Company pharmaceutical manufacturing plant at 50 Imclone Drive in Branchburg, N. J., on March 5, 2021. Mike Segar/ReutersZachary StieberSenior Reporter4/1/2026|Updated: 4/1/20260:00U.S. regulators on April 1 approved an obesity pill called Foundayo from Eli Lilly, adding a second option for consumers who want to take weight loss drugs but desire to avoid injections.Foundayo is a glucagon-like peptide-1 (GLP-1) medication meant to be taken once a day.

spot_imgspot_imgspot_img

Share post:

More like this
Related

Ohio State Agrees to $2.1 Million Federal Settlement Over Undisclosed China Research Ties

Ohio State University has agreed to pay $2.1 million...

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new...

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American...

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with...